Literature DB >> 33639232

Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications.

Junying Lu1, Yuanyuan Huang2, Xiaohao Zhang3, Yang Xu4, Shu Nie5.   

Abstract

Diabetes is a metabolic disorder and its incidence is still increasing. Diabetic vascular complications cause major diabetic mobility and include accelerated atherosclerosis, nephropathy, retinopathy, and neuropathy. Hyperglycemia contributes to the pathogenesis of diabetic vascular complications via numerous mechanisms including the induction of oxidative stress, inflammation, metabolic alterations, and abnormal proliferation of EC and angiogenesis. In the past decade, epigenetic modifications have attracted more attention as they participate in the progression of diabetic vascular complications despite controlled glucose levels and regulate gene expression without altering the genomic sequence. DNA methylation and histone methylation, and acetylation are vital epigenetic modifications and their underlying mechanisms in diabetic vascular complication are still urgently needed to be investigated. Non-coding RNAs (nc RNAs) such as micro RNAs (miRNAs), long non-coding RNA (lncRNAs), and circular RNAs (circ RNAs) were found to exert transcriptional regulation in diabetic vascular complication. Although nc RNAs are not considered as epigenetic components, they are involved in epigenetic modifications. In this review, we summarized the investigations of non-coding RNAs involved in DNA methylation and histone methylation and acetylation. Their cross-talks might offer novel insights into the pathology of diabetic vascular complications.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DNA methylation; Diabetic vascular complications; Histone acetylation; Histone methylation; Non-coding RNAs

Mesh:

Substances:

Year:  2021        PMID: 33639232     DOI: 10.1016/j.phrs.2021.105520

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  6 in total

1.  Long noncoding RNA X-inactive specific transcript regulates NLR family pyrin domain containing 3/caspase-1-mediated pyroptosis in diabetic nephropathy.

Authors:  Jia Xu; Qin Wang; Yi-Fan Song; Xiao-Hui Xu; He Zhu; Pei-Dan Chen; Ye-Ping Ren
Journal:  World J Diabetes       Date:  2022-04-15

2.  Hypermethylation of the Promoter Region of miR-23 Enhances the Metastasis and Proliferation of Multiple Myeloma Cells via the Aberrant Expression of uPA.

Authors:  Qijie Ran; Dehong Xu; Qi Wang; Dongsheng Wang
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

Review 3.  Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis.

Authors:  Irina V Bure; Marina V Nemtsova; Ekaterina B Kuznetsova
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

4.  CircRNA-3302 promotes endothelial-to-mesenchymal transition via sponging miR-135b-5p to enhance KIT expression in Kawasaki disease.

Authors:  Chao Ni; Huixian Qiu; Shuchi Zhang; Qihao Zhang; Ruiyin Zhang; Jinhui Zhou; Jinshun Zhu; Chao Niu; Rongzhou Wu; Chuxiao Shao; Abdullah Al Mamun; Bo Han; Maoping Chu; Chang Jia
Journal:  Cell Death Discov       Date:  2022-06-29

5.  Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy via Novel Biomarkers and Competing Endogenous RNA Network.

Authors:  Mingfei Guo; Yaji Dai; Lei Jiang; Jiarong Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

Review 6.  Potential epigenetic molecular regulatory networks in ocular neovascularization.

Authors:  Qiang Hu; Xue Zhang; Minghao Sun; Bo Jiang; Zhongyu Zhang; Dawei Sun
Journal:  Front Genet       Date:  2022-09-02       Impact factor: 4.772

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.